Clinical Trials Logo

Suicidal Ideation clinical trials

View clinical trials related to Suicidal Ideation.

Filter by:

NCT ID: NCT01918696 Completed - Suicidal Ideation Clinical Trials

Controlled Evaluation of a Computerized Anger-reduction Treatment for Suicide Prevention

Start date: October 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a computerized intervention designed to reduce anger-provoking interpretation biases will reduce suicide risk among individuals with elevated levels of trait anger.

NCT ID: NCT01887990 Completed - Depression Clinical Trials

Treatment of Suicidal Ideation With Intravenous Ketamine Infusion

Start date: May 2012
Phase: N/A
Study type: Interventional

This study is dedicated to achieving better treatments for suicidal thoughts. Specifically, the investigators are studying the effect of a medication called ketamine to quickly treat suicidal thoughts and depression.

NCT ID: NCT01829620 Completed - Clinical trials for Suicidal and Self-injurious Behavior

Military Continuity Project

MCP
Start date: April 2013
Phase: N/A
Study type: Interventional

The investigators propose to utilize text messaging to create and investigate the efficacy of a Continuing Contacts via Text (CCVT) intervention that extends the continuity of care for Service Members with a recent suicide attempt and/or reported suicidal ideation by sending them non-demanding caring text messages at regular intervals over a 12-month period. Participants will be randomly assigned to receive Continuing Contacts via Text (CCVT) in addition to Treatment as Usual (TAU) or TAU alone. Aim 1: To determine if the addition of 12 months of CCVT to TAU (CCVT+TAU) results in lower rates of suicidal ideation and behavior relative to TAU alone. - Hypothesis 1a: Participants assigned to CCVT+TAU compared to TAU alone will experience reduced suicidal ideation at 12-month follow-up. - Hypothesis 1b: Over the 12 months following study enrollment, a smaller proportion of participants assigned to CCVT+TAU vs. TAU alone will have suicide risk incidents (i.e., those requiring medical evacuation or hospital admission). - Hypothesis 1c: Over the 12 months following study enrollment, CCVT+TAU vs. TAU alone will have fewer total number of suicide risk incidents requiring medical evacuation or hospital admission. Aim 2: To test two proposed mechanisms of action of CCVT outcome: 1) reduced "thwarted belongingness" and 2) increased engagement in behavioral health services. - Hypothesis 2a: The effect of CCVT+TAU compared to TAU alone will be mediated by reductions in "thwarted belongingness" from pre to post-study. - Hypothesis 2b: The effect of CCVT+TAU compared to TAU alone will be mediated by increased use of outpatient behavioral health services in the CCVT+TAU condition.

NCT ID: NCT01770587 Completed - Insomnia Clinical Trials

A Sleep-Oriented Intervention for Suicidal Behaviors

Start date: May 2013
Phase: N/A
Study type: Interventional

An open-label trial to investigate the use of a behavioral insomnia treatment for suicidal ideation.

NCT ID: NCT01764074 Completed - Bipolar Disorder Clinical Trials

Brief Sleep Intervention for Bipolar Disorder

Start date: January 2013
Phase: N/A
Study type: Interventional

Individuals with bipolar disorder (BD) experience extreme mood swings, or episodes of depression and (hypo)mania. These episodes are associated with poor functioning, worse course of illness, and high rates of suicidality. It is estimated that between 25 to 65% of individuals with BD attempt suicide and 4 to 19% of individuals with BD eventually die by suicide. Sleep disturbance has been identified as a primary prodromal as well as causal symptom of mood episodes and recently, has been found to be associated with higher rates of suicidal ideation and behavior. Given the role that sleep may have in mood stability and suicidality in BD, it seems imperative to further understand the association of sleep and suicide and how sleep interventions may be useful to reduce suicidality in BD. Thus, the primary aim of this study is to use an innovative home sleep monitoring device, or the Embla, to examine the association of sleep and suicidality in adult outpatients with BD. The Embla is unique in that it is a non-invasive device that can characterize sleep profiles by measuring the degree of sleep fragmentation and percentage of rapid eye movement (REM) sleep. The study duration is five to six weeks such that patients wear the Embla device for Week 1, participate in a brief sleep intervention for suicide during Weeks 2 and 3, and 4, and then wear the Embla device for one more week (Week 5). This intervention consists of three, 60-min sessions and utilizes cognitive-behavioral therapy strategies (e.g., psychoeducation, cognitive re-structuring, problem solving, behavioral activation) to improve sleep disturbance. The investigators expect that individuals at study entry with more sleep disturbance (as measured by the Embla) will report more suicidal ideation and behaviors. The investigators also hypothesize that from pre- to post-intervention, individuals will report less sleep disturbance as well as suicidal ideation and behaviors. Data from this research has immediate and practical implications for providers and their patients as it the first examination of sleep phenotypes and suicide in a high risk population as well as to explore the association of improvements in sleep with suicidality.

NCT ID: NCT01748955 Completed - Depression Clinical Trials

Paroxetine/Bupropion in Depression With Suicide Attempt or Thoughts: fMRI Study

Start date: June 2010
Phase: Phase 4
Study type: Interventional

This study uses functional magnetic resonance imaging (fMRI) to investigate the effects of two different antidepressant medications (Paxil CR versus Wellbutrin XL) on reward processing in depressed patients who have attempted suicide or are currently experiencing suicidal thoughts.

NCT ID: NCT01700829 Completed - Clinical trials for Major Depressive Disorder

Ketamine in the Treatment of Suicidal Depression

Start date: June 2012
Phase: Phase 4
Study type: Interventional

This study is designed to compare the effectiveness of two medications, Ketamine and Midazolam, for rapidly relieving suicidal thoughts in people suffering from depression. The first drug, Ketamine, is an experimental antidepressant that early studies have shown may quickly reduce suicidal thoughts, but we are not sure how well it may work. Midazolam, the comparison drug, is not thought to reduce depression or suicidal thoughts.

NCT ID: NCT01689909 Completed - Depression Clinical Trials

Reducing Suicidal Ideation Through Insomnia Treatment

REST-IT
Start date: December 6, 2012
Phase: Phase 4
Study type: Interventional

Epidemiologic reports have linked insomnia to suicidal ideation and suicide death. However, no studies have determined whether treating insomnia decreases the risk of suicidality. We have new data indicating that (1) the link between insomnia and suicidal ideation holds true in clinical trials of depressed insomniacs, (2) dysfunctional cognitions about sleep are related to suicidal ideas, and (3) treatment of insomnia with hypnotics leads to a reduction of suicidal ideation. We now propose to test whether cautious use of hypnotics in suicidal, depressed insomniacs may reduce suicide risk in a multi-site clinical trial.

NCT ID: NCT01652443 Completed - Suicidal Ideation Clinical Trials

Relationships and Health in the OEF/OIF Veteran Population

Start date: April 2011
Phase: N/A
Study type: Observational

The current study will explore relationships and health in the OEF/OIF Veteran population. Specifically, this study will examine PTSD symptom severity, traumatic brain injury, relationship satisfaction, leisure, general health ratings, feelings of burdensomeness and belongingness, and suicidal ideation.

NCT ID: NCT01652430 Completed - PTSD Clinical Trials

Experiential Avoidance in Combat Veterans With and Without Posttraumatic Stress Disorder

Start date: October 2010
Phase: N/A
Study type: Observational

This study plans to examine if symptoms of PTSD affect how Veterans who have served in combat think and react to certain information, and whether or not this has an influence on suicidal thoughts.